Currently out of the existing stock ratings of Robert Majek, 18 are a BUY (85.71%), 3 are a HOLD (14.29%).

Robert Majek

Work Performance Price Targets & Ratings Chart

Analyst Robert Majek, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 61.11% that have a potential upside of 14.17% achieved within 110 days.

Robert Majek’s has documented 36 price targets and ratings displayed on 6 stocks. The coverage is on the Technology sector.

Most recent stock forecast was given on NOW, ServiceNow at 08-Apr-2025.

Wall Street Analyst Robert Majek

Analyst best performing recommendations are on NEWR (NEW RELIC).
The best stock recommendation documented was for NEWR (NEW RELIC) at 4/3/2020. The price target of $56 was fulfilled within 34 days with a profit of $11.51 (25.87%) receiving and performance score of 7.61.

Average potential price target upside

FSLY Fastly LLNW Limelight Networks NEWR New Relic MSFT Microsoft NOW ServiceNow CTXS Citrix Systems

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$7

$1.61 (29.87%)

$7

7 days ago
(16-Apr-2025)

7/9 (77.78%)

$1.68 (31.58%)

86

Hold

$6

$0.61 (11.32%)

$9

15 days ago
(08-Apr-2025)

21/25 (84%)

$1 (20.00%)

81

Hold

$12

1 months 3 days ago
(20-Mar-2025)

2/5 (40%)

$2.13 (21.58%)

343

Hold

$8

$2.61 (48.42%)

$10

2 months 10 days ago
(13-Feb-2025)

14/15 (93.33%)

$0.03 (0.38%)

106

Hold

$10

$4.61 (85.53%)

$10

3 months 6 days ago
(17-Jan-2025)

9/10 (90%)

$0.71 (7.64%)

122

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Robert Majek is most bullish on?

Potential upside of $227.84 has been obtained for NOW (SERVICENOW)

What Year was the first public recommendation made by Robert Majek?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?